1,073 Shares in Zoetis Inc. (NYSE:ZTS) Bought by Austin Private Wealth LLC

Austin Private Wealth LLC purchased a new stake in Zoetis Inc. (NYSE:ZTS) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 1,073 shares of the company’s stock, valued at approximately $212,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Fairfield Bush & CO. acquired a new position in shares of Zoetis in the first quarter valued at approximately $134,000. Sequoia Financial Advisors LLC increased its position in Zoetis by 5.3% during the 1st quarter. Sequoia Financial Advisors LLC now owns 4,166 shares of the company’s stock worth $786,000 after buying an additional 211 shares during the period. Candriam Luxembourg S.C.A. boosted its position in shares of Zoetis by 3.9% in the first quarter. Candriam Luxembourg S.C.A. now owns 51,581 shares of the company’s stock valued at $9,727,000 after acquiring an additional 1,914 shares during the period. Covestor Ltd grew its stake in shares of Zoetis by 102.8% in the first quarter. Covestor Ltd now owns 724 shares of the company’s stock valued at $137,000 after acquiring an additional 367 shares in the last quarter. Finally, Merit Financial Group LLC boosted its holdings in Zoetis by 92.8% in the 1st quarter. Merit Financial Group LLC now owns 2,342 shares of the company’s stock valued at $442,000 after purchasing an additional 1,127 shares during the period. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ZTS has been the topic of several recent research reports. Piper Sandler raised their target price on shares of Zoetis from $215.00 to $220.00 and gave the stock an “overweight” rating in a report on Tuesday, February 20th. Jefferies Financial Group reiterated a “buy” rating and set a $230.00 target price on shares of Zoetis in a research report on Tuesday, December 19th. The Goldman Sachs Group raised their price target on Zoetis from $190.00 to $226.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. StockNews.com cut shares of Zoetis from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Finally, Barclays increased their price objective on shares of Zoetis from $255.00 to $260.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 14th. Nine equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $224.33.

Zoetis Price Performance

NYSE:ZTS traded up $0.61 on Thursday, hitting $169.12. The company had a trading volume of 3,395,584 shares, compared to its average volume of 2,739,733. Zoetis Inc. has a 52 week low of $151.03 and a 52 week high of $201.92. The company has a current ratio of 3.36, a quick ratio of 2.00 and a debt-to-equity ratio of 1.32. The stock has a market capitalization of $77.43 billion, a price-to-earnings ratio of 33.36, a PEG ratio of 2.53 and a beta of 0.87. The firm has a 50 day moving average of $185.92 and a two-hundred day moving average of $182.24.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Tuesday, February 13th. The company reported $1.24 EPS for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.08). Zoetis had a net margin of 27.43% and a return on equity of 51.25%. The firm had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the company posted $1.15 earnings per share. The firm’s revenue was up 8.5% on a year-over-year basis. On average, research analysts anticipate that Zoetis Inc. will post 5.8 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be issued a $0.432 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $1.73 dividend on an annualized basis and a yield of 1.02%. Zoetis’s dividend payout ratio (DPR) is presently 34.12%.

Insider Buying and Selling

In related news, EVP Roxanne Lagano sold 923 shares of the business’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $173.33, for a total value of $159,983.59. Following the sale, the executive vice president now owns 15,723 shares of the company’s stock, valued at $2,725,267.59. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders have sold a total of 2,209 shares of company stock worth $408,453 in the last ninety days. Company insiders own 0.12% of the company’s stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.